Exploratory evaluation of her2 as a potential new therapeutic target in soft tissue sarcomas

Project objectives

• Evaluation of Her2 expression in cellular models of myxoid liposarcoma, leiomyosarcoma, dedifferentiated liposarcoma, fibrosarcoma and GIST 
• Analysis of the anti-tumor effect of the Her2 inhibitor, Trastuzumab Deruxtecan, in the same cell lines 
• Analysis of the anti-tumor effect of the Her2 inhibitor, Trastuzumab Deruxtecan, in chemo-resistant sarcoma cell models

Start and end date

Project Manager

Coordinating institution of the project

Other Institutions involved

• University of Barcelona